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E-mail address: jarouke@elisabethAbstract Quality of life is of increasing importance in clinical oncology studies.
When analysing publications concerning quality of life in breast cancer, however, the
majority of the articles appear to study health status and not quality of life.
Therefore five recommendations were formulated to apply reading a ‘quality of life’
article. With the use of these recommendations an article can be evaluated and the
clinical significance can be assessed.
q 2004 Elsevier Ltd. All rights reserved.Introduction
In many clinical oncology studies Quality of life
(QoL) is an important outcome measure. However,
interpretation of the published results can be
difficult because of a large range of questionnaires
used and considerable variation in study design.
In the Netherlands, one in every 10 women will
develop carcinoma in situ or invasive carcinoma of
the breast during her life.1 In the late 1970s and
early 1980s several prospective clinical trials
showed that breast conserving surgery (i.e., lum-
pectomy and axillary lymph node dissection; BCS)
followed by radiotherapy was equivalent to modi-
fied radical mastectomy (MRM) concerning 5-year
survival and disease-free survival.2,3 Since these
publications, women with early breast cancer
participate increasingly in treatment decisions.
QoL is an important factor in this process, because4 Elsevier Ltd. All rights reserv
3-539-29-22; fax:C31-13-
.nl (J.A. Roukema).it is thought to be influenced by the type of
treatment the patient receives. When a surgeon
wants to advise his patients about the (dis)advan-
tages of the two surgical treatment modalities, it is
important to have some knowledge of the results of
QoL studies in breast cancer. The purpose of this
article is to evaluate recent QoL studies and provide
insight in the methods and questionnaires used to
evaluate breast cancer patients’ QoL. Recommen-
dations concerning the interpretation of the pub-
lished results are formulated and the clinical
significance of the evaluated studies will be
determined using these recommendations.Quality of Life
Quality of Life
Quality of Life is defined by the World Health
Organisation Quality of Life Group as ‘an individ-
ual’s perception of his/her position in life in the
context of the culture and value systems in whichEJSO (2004) 30, 1051–1057
www.ejso.comed.
A.F.W. van der Steeg et al.1052he/she lives and in relation to his/her goals,
expectations, standards and concerns’.4 In other
words, QoL is a person’s evaluation of his/her
functioning in a wide range of areas. This definition
implies that QoL is subjective and can therefore
only be judged by individuals themselves.Health status
In medical literature, the term QoL is often used
simultaneously with the terms health-related qual-
ity of life (HR-QoL) and health status (HS).
Frequently these three terms are considered inter-
changeable. However, HS and HR-QoL can be
grouped together but are not equivalent to QoL.
HS refers to ‘the defined well-being in terms of
physical, mental, and social condition or function’.5
Thus, HS measures the impact of disease on
functioning6 and patients are asked solely about
their physical possibilities, social activities, and
state of mind and not about their feelings concern-
ing their functioning. Therefore, HS indicates
whether there are limitations whereas QoL also
reflects to what extent a patient is bothered by
these limitations in daily life.Questionnaires
The structure of HS and QoL questionnaires is based
on the definition of health by the WHO being ‘a
state of complete physical, mental and social well-
being and not merely the absence of disease or
infirmity’.7 Therefore, the questionnaires have
three principal domains: the physical domain, the
psychological domain, and the social domain.8 For
HS questionnaires the physical domain refers to
bodily function or its impairment. The psychologi-
cal dimension refers to negative effects on the
psychological functioning, for instance, mood dis-
turbance and level of distress. The social aspect
refers to the ability to perform the daily social role,
for example, in the relationship with partner,
family, or friends. In QoL instruments patients are
also asked about their perception or evaluation of
their functioning in these domains. Another import-
ant difference is the construct of the questions. HS
questionnaires tend to phrase their questions
negative (e.g. Are you limited in any way in doing
either your work or doing household jobs? No/Yes)9
and explore a limited number of aspects whereas
QoL instruments usually cover more aspects and
contain negative and positive stated questions (e.g.
To what extent do you feel that physical pain
prevents you from doing what you need to do? Notat all/A Small amount/A Moderate amount/A Great
deal/An Extreme amount).10
Most of the HS and QoL questionnaires are
generic, implying that the questionnaire was
developed for a general healthy and ill population
and not for a defined selection of individuals. These
generic questionnaires can be supplemented with
disease-, symptom-, or treatment-specific
modules.11Methods
A literature search using MEDLINE and psychINFO
was performed to analyse recent QoL research
concerning early-stage breast cancer. As search
item ‘quality of life’ was used together with ‘breast
neoplasms’, ‘mastectomy’, and ‘breast conserva-
tion’. The references of the articles retrieved
through this search were surveyed and additional
studies were identified. The search covered the
period from January 1985 until July 2003. The
articles had to be written in English. Furthermore,
an article had to focus on the physical, psychologi-
cal, and social aspects. The authors strongly feel
that all three domains of QoL and HS should be
taken into consideration when reaching a judgment
about the QoL or HS of an individual patient or
cohort of patients.
The search resulted in 33 articles. After applying
the selection criteria on these articles and their
reference articles, 20 studies remained (see Table
1). The HS and QoL questionnaires used in these
studies will be discussed in terms of their design and
what they measure.Methodological criteria
HS or QoL questionnaires should meet three
methodological criteria to be considered a useful
instrument: reliability, validity, and responsiveness
to change.32
Reliability
The key types of reliability in this context are
internal consistency and test–retest reliability.
Internal consistency refers to the homogeneity of
questions in a (sub)scale. Each scale in a certain
questionnaire represents a factor of interest, such
as psychological functioning. Body image is an
example of a subscale within the psychological
domain. Depending on the number of questions in a
(sub)scale, internal consistency (Crombach’s alpha)
Table 1








Schain 198312 Retrospective 1 QoL 1 10 m po
De Haes 198513 nm 1 HS 1 11 m po
De Haes 198614 nm 1 HS 2 11 m 18 m po
Levy 198915 Retrospective 2 HS 2 3 d, 3 m po
Ganz 199216 Prospective 5 HS 4 1 m, 3 m, 6 m,
12 m po
Levy 199217 Prospective 3 HS 3 pre-op, 3 m, 15
m po
Hughes 199318 Prospective 4 3x HS, 1xQoL 2 pre-op, 2 m po
Shimozuma
199519
Prospective 1 HS 4 pre-op, 0–2 m,
3–12 m, 13–24 m
po
Ganz 199620 Retrospective 5 HS 2 2 y, 3 y po
Gilbar 199721 Retrospective 1 HS 1 3–7 m po
Dorval 199822 Prospective 4 HS 3 3 m, 18 m, 8 y po
Jahkola 199823 Retrospective 2 QoL 1 3–8 y po
Pusic 199924 Retrospective 2 HS 1 3 y po
Wapnir 199925 Retrospective 1 HS 1 1–7 y po
Cohen 200026 Retrospective 2 HS n.m. 1–5 y po
King 200027 Prospective 3 HS 2 3 m, 12 m po
Rowland 200028 Retrospective 6 HS 1 1–5 y po
Holzner 200129 Retrospective 2 HS 1 4–7 y po
Janni 200130 Retrospective 1 HS 1 46 m po
Nissen 200131 Prospective 3 HS 7 pre-op, 1, 3, 6,
12, 18, 24 m po
Note: nm, not mentioned; QoL, Quality of Life; HS, Health Status; pre-op, pre-operative; po, post-operative; d, days; m, months; y,
years.
Quality of life and health status in breast carcinoma 1053should be at least 0.70. To measure test–retest
reliability repeated assessments evaluating an
unchanged characteristic are carried out. A test is
considered reliable when the reliability coefficient
is above 0.80 in a test–retest set-up.33
Validity
Validity implies that a test measures what it is
supposed to measure and refers to the degree of
non-random or systematic bias.34 Validity can be
determined in different ways. First, there is the
inter-scale correlation for questionnaires that con-
sist of various scales. The scores of conceptually
related scales (e.g., physical functioning and
fatigue) correlate substantially with each other.
This is called construct validity. Second, the scores
of a questionnaire need to be able to discriminate
between subgroups of patients differing in clinical
status, called discriminant validity.35 The respon-
siveness of a test (also known as clinical validity) is
the sensitivity of a test to changes in QoL/HS over
time or after an intervention, such as treatment.36
In addition to these methodological criteria,
instruments need to be self-administered since itis known that physicians or spouses tend to either
underestimate or overrate the QoL of patients.37
The questionnaire has to be multi-dimensional
covering the physical, psychological, and social
domain, relatively brief (taking less than 15 min-
utes to complete), and have a good acceptability to
patients.34 To ensure that measurements are
comparable after translation of a questionnaire,
semantic equivalence has to be achieved. To this
extent standardized translation procedures using
forward and back translations have been
formulated.11Number of questionnaires used in a study
In the selected articles the number of question-
naires varies from one12–14,19,21,25,30 to six.28 When
researchers applied more than one questionnaire,
each test was focused on one specific domain of
QoL/HS. The authors then tend to base general
conclusions concerning the QoL/HS of the patients
on a combination of the different scores. Combining
the scores however, may not justify the outcome of
each individual QoL/HS questionnaire.
A.F.W. van der Steeg et al.1054Furthermore, it is important to use the appropriate
questionnaire for the posed hypothesis. Kemmler
et al. showed in their study that two HS ques-
tionnaires applied to the same study group gave
completely different results and were not inter-
changeable.38 Usually the specific characteristics of
a questionnaire can be found either in the reports
describing the initial development and testing of
the instruments or in the manuals.Type of questionnaires
The first step in analysing the results is to determine
whether questionnaires used measure HS or QoL. A
HS questionnaire solely measures the presence of
impairment in each of the three domains, whereas a
QoL questionnaire asks about satisfaction. When a
patient is not capable to walk the stairs without
difficulty she will have a low score in the physical
domain in a HS questionnaire. However, when the
same patient is not bothered at all by this problem
she will score normal in a QoL questionnaire. So the
same impairment can lead to completely different
scores for HS and QoL and, thus, to completely
different results and conclusions. Therefore, the
type of questionnaire has to be in line with the aim
of a study. Another important factor influencing the
outcome of HS and QoL instruments is how the
questions are phrased. HS questionnaires tend to
formulate their questions negatively which may
result in more pessimistic answers from the patient.
QoL questionnaires use positive and negative
formulations, thus preventing a negative trend in
the answers.Study design
Breast cancer is in the majority of patients not a
fatal illness, but a chronic disease that often
requires treatment over the course of months or
even years with complex and toxic therapies.
Several studies measure the development of
QoL/HS over time. When statements are made
about the course of QoL/HS it is important to have a
clearly defined starting point, preferably before
treatment commences. Thus, the study design
needs to be prospective.
In many cases QoL/HS is only one of the outcome
measures in a study. It is known that patients
participating in clinical trials have a better prog-
nosis, presumably because of standardized care or
due to particular selection criteria for trial partici-
pation.39 One could argue that this better prognosisand the attention given to the patients because of
their participation in a study in itself results in a
better QoL/HS. It is important that this possible
bias is acknowledged.Frequency and moment of testing
In general, when breast cancer is diagnosed, QoL is
negatively influenced. Surgical treatment and
adjuvant radiotherapy or chemotherapy also have
a profound negative influence on the reported
QoL/HS.40–42 When treatment results in disease-
free survival women tend to become less concerned
and QoL/HS improves. In essence, ‘time heals all
wounds’. This phenomenon is also known as
response shift. When researchers are interested in
the course of QoL/HS over time the questionnaires
need to be administered more than once and over a
longer period of time. Because of the large impact
of treatment and adjuvant treatment on QoL/HS
timing of questionnaire completion must be care-
fully considered.Recommendations
Based on the aspects of QoL/HS studies presented
above we suggest the following recommendations
for the interpretation of the results of such studies:1. Determine whether QoL is your subject of
interest or merely the functional consequences
of breast cancer treatment. For the latter HS
studies are sufficient.2. Check the keywords for QoL and HS to determine
in which category the authors place their
research.3. Analyse the hypothesis of the researchers and
ascertain the goal of the study. Do the authors
wish to establish impairment of functioning or
are they interested in the satisfaction of their
research population with their functioning.
Verify that the hypothesis is represented cor-
rectly by the choice of keywords.4. Make sure that the study design is able to
confirm the hypothesis of the article. When the
authors wish to establish a certain development
of QoL/HS over time the study design needs to
provide repeated measurements and an ade-
quate follow-up period. Ascertain whether
QoL/HS is the main outcome measure or part
of a larger research question as this may
influence the reported results.5. Evaluate the questionnaires used. Did the
authors use an appropriate questionnaire to
Quality of life and health status in breast carcinoma 1055examine their hypothesis? When the article is
categorized as a QoL study, make sure that only
QoL questionnaires are used. What is the number
of questionnaires used and are the authors able
to explain why these specific questionnaires
were used. Make sure that the results of
different questionnaires are discussed separ-
ately and not combined to reach one general
conclusion.
When these recommendations are followed, we
feel that the reported results are useful for a
surgeon when advising patients with early-stage
breast cancer.Analysis of the selected articles
The 20 selected articles that met the selection
criteria are now analysed using the aforementioned
recommendations to determine their clinical
usefulness.
Recommendation 1
We were interested in QoL studies, HS was not used
as a search item in our initial search. When, in
retrospect, HS is added to the search list one
additional article is found.43 So, although the
majority of these studies are HS studies this key
word is seldom used.
Recommendation 2
Nine of the included articles used QoL as a
keyword,17,19,21,22,25–27,30,31 but none actually used
QoL questionnaires and therefore these studies
cannot be categorized as QoL studies. The three
studies that did apply QoL questionnaires12,18,23 did
not use QoL as a keyword. None of the included
articles used Health Status as a keyword, even
though 17 of the 20 studies used only HS ques-
tionnaires. So, concerning recommendation 2 we
conclude that most often the key words HS and QoL
do not reflect the content of the study.
Recommendation 3
The majority of the included articles are descrip-
tive studies without an apparent hypothesis. Four
studies are based on a hypothesis concerning the
effect of surgical treatment of breast cancer on the
QoL of the patients.13,21,25,26 These studies, how-
ever, have not used QoL questionnaires to examine
the hypothesis.Recommendation 4
The studies varied largely in design. Of the four
articles based on a hypothesis, one reported the
first results of a longitudinal study, therefore its
conclusions may change over time.13 In another
study, the issue of QoL was a secondary aim and
although the authors felt that time since surgery is a
factor of influence, they did not mention a time
frame in the study design.26 Two articles assumed
that BCS resulted in a better QoL and verified this
hypothesis by using HS questionnaires which were
applied only once to the patients in a retrospective
setting.21,25
Fifteen articles were descriptive studies. The
authors either determined the development of
HS/QoL over time depending on the treatment
received by the patient14–19,22,29,31 or compared
HS/QoL for two treatment modalities (MRM and
BCS) at certain moment after treatment.12,23,24,30
In two descriptive studies, patients were divided in
study groups based on time since surgery. The
women received the questionnaires only once, but
at different time frames after surgery. Conclusions
were then drawn concerning the development of HS
over time.28,29
Seven studies were retrospective in na-
ture12,15,23,24,28–30 and in two of them the HS/QoL
issue was added in hindsight to an already existing
research protocol.12,15 HS/QoL was one of the study
outcome measures and not always the primary
research question in seven of the included
studies.14,16,17,23,24,30,31 It was the sole outcome
of interest in six articles.18,19,22,27–29 When HS/QoL
was not the only outcome measure of interest, the
reported results may have been influenced posi-
tively by the extra attention paid to the patients
during the study and the fact that treatment
followed a strict protocol. None of the authors
took this confounding factor into consideration.
When statements were made about HS/QoL over
time a baseline measurement, preferably before
surgery, should have been included in the study.
Only four studies had a baseline measurement.17–19,
31 The other studies that applied the questionnaires
more than once started post operative and the
timing of the first measurement seemed ad random.Recommendation 5
Table 1 shows that only three studies used QoL
questionnaires, either as the only questionnaire12,23
or in combination with HS questionnaires.18 How-
ever, all 20 studies are described as QoL-research.
Seven studies used one questionnaire to assess
A.F.W. van der Steeg et al.1056HS or QoL, in the other the number of question-
naires varied from two to six. All authors claimed
that the questionnaires used in their study were QoL
instruments. Most authors explained the purpose of
the questionnaire and the specific domains
assessed. However, in most articles the psycho-
metric qualities of the questionnaires used were not
specified or even mentioned. Thus, the quality of
the questionnaires used could not be established
when reading the articles.
Finally, all studies that used more than one
questionnaire combined the results of the individ-
ual questionnaires to reach a general conclusion
about HS/QoL.Conclusion
After evaluation of the included articles using the
aforementioned recommendations we feel that
none of these studies is a genuine Quality of Life
study that truly examines the development of QoL
over time after surgical treatment for breast
cancer. Therefore, one should be careful to ground
clinical advice to individual patients concerning
their treatment on these ‘QoL’ studies.References
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